ArticleClinical drug investigation2024
Overall Survival Benefit with Sacituzumab Govitecan in Metastatic Breast Cancer: A Post Hoc Interaction Analyses of a Randomized Controlled Trail.
Yu-Wei Qiao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.